UnitedHealthcare
Hemlibra (emicizumab-kxwh)
Drugs for the Blood : Drugs for the Blood
  • Step Therapy Applies
  • Prior Authorization: Hemophilia A (Factor VIII):
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

    Hemophilia A or B with Inhibitor:
    PA Applies
  • Hemophilia A (Factor VIII):
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Dosing Limit(s): N/A
    Diagnosis Type(s): 1 of Mild;Moderate;Severe
    Diagnosis Treatments: 1 of Bleeding episodes;Routine propylaxis
    Treatment Center Required: Yes

    Hemophilia A or B with Inhibitor:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Dosing Limit(s): N/A
    Diagnosis Type(s): Unspecified
    Diagnosis Treatments: Routine propylaxis
    Treatment Center Required: No
    Dosing Limits Exist: No